Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3
2(40.0%)
N/A
2(40.0%)
Phase 4
1(20.0%)
5Total
Phase 3(2)
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07319104Not Yet Recruiting

Liquid Biopsy in Early Colorectal Lesions

Role: collaborator

NCT06541652Recruiting

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Role: collaborator

NCT04348838Recruiting

Prospective Cohort of Patients With Hepatocellular Carcinoma in France

Role: collaborator

NCT05206487Not ApplicableRecruiting

Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME)

Role: collaborator

NCT02550704Not ApplicableCompleted

Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients

Role: collaborator

NCT00546546Phase 4Completed

Early Immunosuppressants in Crohn's Disease

Role: collaborator

NCT01877135Unknown

Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients

Role: collaborator

NCT02325323Unknown

Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia

Role: collaborator

NCT00224679Phase 3Terminated

APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence

Role: collaborator

NCT00723047Phase 3Completed

Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial

Role: collaborator

All 10 trials loaded